Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Gets California OK for Clinical Lab

NEW YORK (GenomeWeb News) – California health officials have cleared Transgenomic to offer its molecular lab services in the state by certifying its lab, the company said today.

The company said it expects to start marketing a number of its services to California doctors right away, including tests for mitochondrial disorders, oncology, hematology, molecular pathology, and inherited diseases.

The company said its lab is CLIA certified, is compliant with Good Laboratory Practices, and is accredited by the College of American Pathologists.

Company CEO Craig Tuttle said in a statement that Transgenomic underwent a "rigorous certification process" to obtain the state license. "The state of California represents the largest market opportunity in the United States" for the company's molecular lab testing services, he added.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.